University of Minnesota. Driven to Discover.
High demand, production problems, and lack of raw materials contribute to the shortage, which has hindered immunization campaigns at a crucial time.
ACIP spent several months reviewing clinical trial data that showed two doses in younger adolescents prompted an immune response similar to or higher than in young adults.
After a rigorous 6-year review, an expert panel declares the region the first in the world to eliminate the disease.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.